http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7332577-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f11390a0601d6520c1d8695c6a4f6744
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
filingDate 2005-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aea15d1c19b45d709d8c9afe66f0c92a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a2d0d8416900acbb1127717a29cea4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73009061ff98449a206bf8a21e498649
publicationDate 2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7332577-B2
titleOfInvention Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them
abstract The invention discloses a purified albumin solution of human origin with low prekallicrein activator (PKA) activity and stability over time characterised in that it has an antithrombin content equal to or greater than 0.03 mg/g of albumin, and a process for production thereof by the partial extraction of the antithrombin during fractionation of the human plasma.
priorityDate 2004-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5094949-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0246439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5407671-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4251510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4378346-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0056768-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0253198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9731947-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004047859-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1413312-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID541924
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3827
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID306761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID213
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280833
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397731
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85302
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WUW1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID460916
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462304
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478666
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034206
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID424957
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439201
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16644
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ91VR8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11657
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID489090
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2161
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280789
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID288001
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID247744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID558311

Total number of triples: 60.